Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05356988 · ClinicalTrials.gov registry record · NA
Health and Energy Through Active Living Every Day After Cancer Intervention for Cancer Survivors
A NA study, sponsored by American Cancer Society.
- Completed
- Registry status
- NA
- Development phase
- 415
- Enrollment target
NCT05356988: Completed NA study, sponsored by American Cancer Society.
NCT05356988 is a NA study that has completed, run by American Cancer Society. The registered enrollment target is 415 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05356988, a NA study, has completed, sponsored by American Cancer Society.
- COMPLETED
- Registry status
- NA
- Development phase
- 415 participants
- Enrollment target
Study Summary
The purpose of the Health and Energy through Active Living Every Day (HEALED) intervention, is to examine the effect of a web-based intervention on changes in device-measured physical activity (light and moderate-to-vigorous intensity aerobic) and sedentary behavior. The purpose of this study is intended for survivors of a cancer with a 5-year survival (at Stage I, II, and III) of at least 45% that has a strong level of evidence for association with physical inactivity according to the 2018 PA Guidelines Advisory Committee Report (breast, colon, endometrium, kidney, bladder, multiple myeloma). In line with social cognitive theory behavior change techniques, participants will be provided information and skills necessary to be more physically active and less sedentary after a cancer diagnosis. New materials will be disseminated biweekly through a website open only to participants, and include at-home exercise demonstration videos, research news, discussion boards, success stories, infographics for exercise recommendations, etc.
Primary Outcome
Device-measured sedentary time with research-grade accelerometer
Interventions
- BEHAVIORAL Physical activity experiment
- BEHAVIORAL Balance and flexibility control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 415 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2023-09-24 |
| Phase | NA |
What the finished NCT05356988 record still lists
NCT05356988 is an interventional study that assigns participants to a tested intervention. The registered 415 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 2 interventions - of which Physical activity experiment is the first listed.
NCT05356988 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05356988 about?
NCT05356988 is a clinical study titled "Health and Energy Through Active Living Every Day After Cancer Intervention for Cancer Survivors". The purpose of the Health and Energy through Active Living Every Day (HEALED) intervention, is to examine the effect of a web-based intervention on changes in device-measured physical activity (light and moderate-to-vigorous intensity aerobic) and sedentary behavior. The purpose of this study is int...
What is the current status of trial NCT05356988?
This trial is currently completed. It is a NA study. The enrollment target is 415 participants. The study started on 2022-06-01. Estimated completion is 2023-09-24.
What interventions are being tested in trial NCT05356988?
The interventions under investigation include: Physical activity experiment (BEHAVIORAL), Balance and flexibility control (BEHAVIORAL).
Who is sponsoring clinical trial NCT05356988?
This trial is sponsored by American Cancer Society, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05356988's enrollment target sits among peer trials
415 241st of 2000 higher than 1,760 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05142605 · 415 participants · NA
Evaluation of Grief Therapy Approaches for Bereaved Parents
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
- NCT05007782 · 416 participants · Phase 1
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
- NCT05520099 · 416 participants
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI